Antioxidant nitroxides and nitrones as therapeutic agents
US6852889B2 · kind B2 · utility
24Cited by
4References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 30, 2004 |
| Grant date | Feb 8, 2005 |
| Priority date | — |
| Expiry date | Jan 30, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel adamantane compounds having one of the following formulas: The present invention also relates to compositions and methods for treating and/or preventing neurological and inflammatory disorders in a patient by administering a therapeutically effective amount of the compounds of formula (I), (II) or (III) and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.